Statins: Side effects and drug interactions
نویسندگان
چکیده
منابع مشابه
Antiretroviral Drug Interactions and Adverse Side Effects
The complexity of antiretroviral therapy, coupled with the lifelong duration of treatment, presents the need for extensive management of drug interactions and adverse effects. This article includes an extensive discussion of drug interactions involving antiretroviral agents and other medications (eg, antibiotics, oral contraceptives, H2 antagonists, and lipid-lowering agents) commonly used in i...
متن کاملDrug interactions with statins.
The 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are generally well tolerated as monotherapy. Statins are associated with two important adverse effects, asymptomatic elevation in liver enzymes and myopathy. Myopathy is most likely to occur when statins are administered with other drugs. Statins are substrates of multiple drug transporters (including OAT- -P1B1,...
متن کاملDrug interactions and the statins.
Drug interactions commonly occur in patients receiving treatment with multiple medications. Most interactions remain unrecognized because drugs, in general, have a wide margin of safety or because the extent of change in drug levels is small when compared with the variation normally seen in clinical therapy. All drug interactions have a pharmacokinetic or pharmacodynamic basis and are predictab...
متن کاملStatins in therapy: Cellular transport, side effects, drug-drug interactions and cytotoxicity - the unrecognized role of lactones
A molecular orbital computational study of the statins and a comprehensive review of the literature have found that the lactone forms of statins play a major role in the transport of statins across the cell membrane, and in the metabolism and clearance from the body. The neutral lactone and acid statin species are preferentially transported across the cell membrane and consequentially preferent...
متن کاملDrug-drug interactions with statins: will pitavastatin overcome the statins' Achilles' heel?
BACKGROUND As the clinical complexity of patients at high cardiovascular risk and with multiple comorbid conditions increases, so does the potential for drug-drug interactions (DDIs). Large retrospective studies in various clinical settings have shown that an unacceptably large proportion of patients are coprescribed a statin with potentially interacting therapies, suggesting that the impact of...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Scripta Medica
سال: 2011
ISSN: 2490-3329,2303-7954
DOI: 10.5937/scrimed1102084k